<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8</volume><submitter>Rui M</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Several drugs currently are available for the treatment of Crohn's disease, including non-biological agents such as anti-inflammatory agents, steroids, immunosuppressive agents, and biologic agents such as anti-tumor necrosis factor (TNF), anti-α4β7 integrin, anti-alpha-4 integrin and anti-interleukin 12/23. However, the choice of treatments for induction and maintenance is still a challenge. The relevant comparison between non-biologic agents and biologic agents is few. In our research, we aimed to help making decisions, as well as providing clinicians and patients with medication references. &lt;b>Methods:&lt;/b> We searched MEDLINE, Embase, and the Cochrane Central Register of controlled trials for relevant randomized controlled trials published through to July 2020 and sys</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>679258</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8440847</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Will the Inducing and Maintaining Remission of Non-biological Agents and Biological Agents Differ for Crohn's Disease? The Evidence From the Network Meta-Analysis.</pubmed_title><pmcid>PMC8440847</pmcid><pubmed_authors>Ma A</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Meng R</pubmed_authors><pubmed_authors>Shi F</pubmed_authors><pubmed_authors>Rui M</pubmed_authors><pubmed_authors>Shang Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Fei Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Will the Inducing and Maintaining Remission of Non-biological Agents and Biological Agents Differ for Crohn's Disease? The Evidence From the Network Meta-Analysis.</name><description>&lt;b>Background:&lt;/b> Several drugs currently are available for the treatment of Crohn's disease, including non-biological agents such as anti-inflammatory agents, steroids, immunosuppressive agents, and biologic agents such as anti-tumor necrosis factor (TNF), anti-α4β7 integrin, anti-alpha-4 integrin and anti-interleukin 12/23. However, the choice of treatments for induction and maintenance is still a challenge. The relevant comparison between non-biologic agents and biologic agents is few. In our research, we aimed to help making decisions, as well as providing clinicians and patients with medication references. &lt;b>Methods:&lt;/b> We searched MEDLINE, Embase, and the Cochrane Central Register of controlled trials for relevant randomized controlled trials published through to July 2020 and sys</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-18T11:43:54.759Z</modification><creation>2025-05-18T11:43:54.759Z</creation></dates><accession>S-EPMC8440847</accession><cross_references><pubmed>34540859</pubmed><doi>10.3389/fmed.2021.679258</doi></cross_references></HashMap>